Open Access
RESIDENT’S CORNER
Inguinal canal recurrence of colorectal adenocarcinoma following cytoreductive surgery and intraperitoneal hyperthermic chemotherapy
Jeffrey J. Tomaszewski, Marc C. Smaldone, Ronald M. Benoit
Department of Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Address correspondence to Dr. Jeffrey J. Tomaszewski,
Department of Urology, Kaufman Building, Suite 700, 3471
Fifth Avenue, Pittsburgh, PA,15213 USA
Canadian Journal of Urology 2008, 15(6), 4428-4430.
Abstract
Peritoneal carcinomatosis, the second most common cause
of death among patients with colorectal carcinoma, may
be managed with cytoreductive surgery and adjuvant
intraoperative peritoneal hyperthermic chemotherapy
(IHPC). We present the case of a 35-year-old male with
locally recurrent colorectal adenocarcinoma in the inguinal
canal and testis following intraperitoneal debulking and
IPHC. When communicating with the peritoneal cavity,
the inguinal canal may act as an anatomic sanctuary site
and allow peritoneal carcinomatosis to escape the effects
of intraperitoneal chemotherapy.
Keywords
spermatic cord, sanctuary site, recurrence, intraperitoneal hyperthermic chemotherapy
Cite This Article
APA Style
Tomaszewski, J.J., Smaldone, M.C., Benoit, R.M. (2008). Inguinal canal recurrence of colorectal adenocarcinoma following cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Canadian Journal of Urology, 15(6), 4428–4430.
Vancouver Style
Tomaszewski JJ, Smaldone MC, Benoit RM. Inguinal canal recurrence of colorectal adenocarcinoma following cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Can J Urology. 2008;15(6):4428–4430.
IEEE Style
J.J. Tomaszewski, M.C. Smaldone, and R.M. Benoit, “Inguinal canal recurrence of colorectal adenocarcinoma following cytoreductive surgery and intraperitoneal hyperthermic chemotherapy,” Can. J. Urology, vol. 15, no. 6, pp. 4428–4430, 2008.
Copyright © 2008 The Canadian Journal of Urology.